Your Prostrate.com logo
Google
Web yourprostate.com.au

Prostate News Archive

01-Nov-2011

  • Exelixis Falls on FDA Prostate Cancer Trial Design Setback

    SOUTH SAN FRANCISCO, Calif. (TheStreet) -- Exelixis faces the possibility of a lengthy delay in the approval process for its experimental prostate cancer drug cabozantinib because U.S. regulators are refusing to sign off on the design of a pivotal clinical trial. The setback introduces new risk into the development of the promising prostate cancer drug, which caused investors to flee Exelixis ...


  • Prostate Cancer Expert Dr. David Samadi to Perform Life-Saving Robotic Prostatectomy Surgery in Netherlands

    NEW YORK, NY-- - prostate cancer expert, Dr. David Samadi, continues his dedication to improving medical care worldwide and increasing accessibility of medical technology by traveling to the Netherlands ...


  • Prostate Cancer Patients Considering Suicide May Find Help in New Concept

    Oct. 31, 2011 - Men with prostate cancer are twice as likely to commit suicide, but a method where they put intrusive thoughts into words may reduce this risk, reveals research at the Sahlgrenska Academy at the University of Gothenburg, Sweden.


  • New findings could lower risk of suicide in men with prostate cancer

    Men with prostate cancer are twice as likely to commit suicide, but a method where they put intrusive thoughts into words may reduce this risk, reveals research at the Sahlgrenska Academy at the University of Gothenburg, Sweden.


  • Prostate Cancer Roundtable Expresses Concern over Federal Recommendations Impeding Access to the PSA, a Key Cancer ...

    Contact: Scott Williams, +1-202-543-6461 ext. 101


  • Back to Prostate News Archive